Clinical Trials Logo

Refeeding Syndrome clinical trials

View clinical trials related to Refeeding Syndrome.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06054139 Recruiting - Refeeding Syndrome Clinical Trials

Risk Factors for Refeeding Syndrome in the Surgical Intensive Care Unit

Start date: June 9, 2023
Phase:
Study type: Observational

Refeeding Syndrome is a condition that occurs when patients who are undernourished or undernourished suddenly start overfeeding, causing electrolyte disturbances and vitamin deficiencies, resulting in neurological and cardiac problems. It may even result in death. It is aimed to prevent the development of Refeeding Syndrome with nutrition in accordance with the guidelines. The aim of this study is to determine the risk factors for Refeeding Syndrome in Intensive Care Unit (ICU).

NCT ID: NCT04005300 Recruiting - Critical Illness Clinical Trials

Application of Prophylactic Low Calorie Feeding in Critically Ill Patients With High-risk Refeeding Syndrome

Start date: July 1, 2019
Phase: N/A
Study type: Interventional

Critically ill patients with high-risk nutrition are often at risk of refeeding syndrome(RFS), that the incidence of RFS is as high as 30-50%. It is sure that patients with refeeding syndrome were treated with restrictive enteral nutrition, but the definition of refeeding syndrome is not uniform, and there is still a lack of awareness high-risk patients of RFS to receiving early empirical low-calorie feeding intervention. So, we designed the study which is divided into three stages. Firstly, the monitoring rate of RFS was reviewed to evaluate the incidence of RFS in general ICU. Secondly, the best diagnostic criteria of RFS were prospectively defined. Finally, on this basis, it is assessed whether early low-calorie feeding could improve prognosis in high-risk patients with RFS.

NCT ID: NCT02621229 Recruiting - Anorexia Nervosa Clinical Trials

Refeeding Syndrome in Anorexia Nervosa

Start date: December 2015
Phase: N/A
Study type: Interventional

The purpose of this multi-center randomized controlled trial is to compare lower calorie refeeding to higher calorie refeeding for hospitalized adolescents and young adults with AN. The investigators will compare efficacy (achievement and maintenance of clinical remission at 12 months), safety during hospitalization, and cost effectiveness (including costs of initial and re hospitalization, 12 month follow up and safety/adverse events).